Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial
Elsevier ·
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial. // The Lancet Regional Health - Europe. – URL: https://www.sciencedirect.com/science/article/pii/S2666776226002917?dgcid=rss_sd_all
Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial. The Lancet Regional Health - Europe. https://www.sciencedirect.com/science/article/pii/S2666776226002917?dgcid=rss_sd_all
“Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial.” The Lancet Regional Health - Europe.
@article{article69263,
title = {Microwave ablation versus stereotactic body radiotherapy for oligometastatic colorectal liver metastases (LAVA-CRLM): a prospective, randomised, phase II trial},
journal = {The Lancet Regional Health - Europe},
url = {https://www.sciencedirect.com/science/article/pii/S2666776226002917?dgcid=rss_sd_all}
}